Publication Cover
Neurological Research
A Journal of Progress in Neurosurgery, Neurology and Neurosciences
Volume 37, 2015 - Issue 5: A dynamic stroke treatment paradigm
90
Views
1
CrossRef citations to date
0
Altmetric
Special Issue Articles

Recent advances in atrial fibrillation and stroke

Pages 381-384 | Received 14 Sep 2014, Accepted 26 Feb 2015, Published online: 15 Apr 2015

References

  • Hackam DG, Spence JD. Combining multiple approaches for the secondary prevention of vascular events after stroke: a quantitative modeling study. Stroke. 2007;38(6):1881–5.
  • Bogiatzi C, Wannarong T, McLeod AI, Heisel MJ, Hackam DG, Spence JD. SubtyPes of ischAemic stRoKe cLassification systEm (SPARKLE) incorporating measurement of carotid plaque burden: a new validated tool for the classification of ischemic stroke subtypes. Neuroepidemiology. 2014;42:243–51.
  • Ozdemir AO, Tamayo A, Munoz C, Dias B, Spence JD. Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci. 2008;275(1–2):121–7.
  • Gladstone DJ, Bui E, Fang J, Laupacis A, Lindsay MP, Tu JV, et al. Potentially preventable strokes in high-risk patients with atrial fibrillation who are not adequately anticoagulated. Stroke. 2009;40(1):235–40.
  • Spence JD. Stroke: atrial fibrillation, stroke prevention therapy and aging. Nat Rev Cardiol. 2009;6(7):448–50.
  • Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8.
  • Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370–5.
  • Gladstone DJ, Spring M, Dorian P, Thorpe K, Panzov V, Hall J, et al. Atrial fibrillation detection in patients with cryptogenic stroke: the EMBRACE randomized trial. N Engl J Med. 2014;370(26):2467–77.
  • Spence JD. Atrial fibrillation and stroke prevention: is warfarin still an option? Yes: debate at the controversies in neurology congress, Beijing October 2011. J Neural Transm. 2013;120(10):1447–51.
  • Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink DN. Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ. 2013;185(2):E121–7.
  • Reilly PA, Lehr T, Haertter S, Connolly SJ, Yusuf S, Eikelboom JW, et al. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (randomized evaluation of long-term anticoagulation therapy). J Am Coll Cardiol. 2014;63(4):321–8.
  • Goette A. Novel oral anticoagulants for stroke prevention in atrial fibrillation: key trial findings and clinical implications. Trends Cardiovasc Med. 2013;23(4):128–34.
  • Spence JD. Nutrition and stroke prevention. Stroke. 2006;37(9):2430–5.
  • Spence JD. Nutrition in stroke prevention. US Neurol. 2013;9(1):45–51.
  • Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;6(9):830–8.
  • Spence JD, Stampfer MJ. Understanding the complexity of homocysteine lowering with vitamins: the potential role of subgroup analyses. JAMA. 2011;306(23):2610–1.
  • Spence JD. B vitamin therapy for homocysteine: renal function and vitamin B12 determine cardiovascular outcomes. Clin Chem Lab Med. 2013;51(3):633–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.